{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:12:03Z","timestamp":1790507523293,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.ejmech.2014.02.049","type":"journal-article","created":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T14:03:42Z","timestamp":1392818622000},"page":"397-407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Copper complexes with phosphonium containing hydrazone ligand: Topoisomerase inhibition and cytotoxicity study"],"prefix":"10.1016","volume":"76","author":[{"given":"Shin Thung","family":"Chew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kong Mun","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze Koon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mok Piew","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuen Yew","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kae Shin","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kong Wai","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2014.02.049_bib1","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1021\/cr068207j","article-title":"Direct cellular responses to platinum-induced DNA damage","volume":"107","author":"Jung","year":"2007","journal-title":"Chemical Reviews"},{"key":"10.1016\/j.ejmech.2014.02.049_bib2","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1039\/B715903J","article-title":"Towards the rational design of platinum(II) and gold(III) complexes as antitumour agents","author":"Wang","year":"2008","journal-title":"Dalton Trans"},{"key":"10.1016\/j.ejmech.2014.02.049_bib3","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jinorgbio.2008.11.016","article-title":"Inhibition of cancer cell growth by ruthenium(II) cyclopentadienyl derivative complexes with heteroaromatic ligands","volume":"103","author":"Helena Garcia","year":"2009","journal-title":"Journal of Inorganic Biochemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib4","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1021\/ic900009j","article-title":"Ligand-based neutral ruthenium(II) arene complex: selective anticancer action","volume":"48","author":"Wu","year":"2009","journal-title":"Inorganic Chemistry Communications"},{"key":"10.1016\/j.ejmech.2014.02.049_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/187152009787313837","article-title":"Copper complexes as anticancer agents","volume":"9","author":"Marzano","year":"2009","journal-title":"Anti-Cancer Agents in Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib6","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.1021\/jm0601248","article-title":"Synthesis, characterization, and in\u00a0vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand","volume":"49","author":"Marzano","year":"2006","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib7","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1021\/om400340a","article-title":"S-Propargylthiopyridine phosphane derivatives as anticancer agents: characterization and antitumor activity","volume":"32","author":"Garc\u00eda-Moreno","year":"2013","journal-title":"Organometallics"},{"key":"10.1016\/j.ejmech.2014.02.049_bib8","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/med.20174","article-title":"Copper in diseases and treatments, and copper-based anticancer strategies","volume":"30","author":"Tisato","year":"2010","journal-title":"Medicinal Research Reviews"},{"key":"10.1016\/j.ejmech.2014.02.049_bib9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1021\/jm00368a024","article-title":"Novel N-hydroxyguanidine derivatives as anticancer and antiviral agents","volume":"27","author":"Tai","year":"1984","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib10","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1021\/jm00164a023","article-title":"Design, synthesis, testing, and quantitative structure\u2013activity relationship analysis of substituted salicylaldehyde Schiff bases of 1-amino-3-hydroxyguanidine tosylate as new antiviral agents against coronavirus","volume":"33","author":"Wang","year":"1990","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib11","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1016\/j.ejmech.2011.05.001","article-title":"Evaluation of DNA binding, DNA cleavage, protein binding and in\u00a0vitro cytotoxic activities of bivalent transition metal hydrazone complexes","volume":"46","author":"Krishnamoorthy","year":"2011","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib12","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jinorgbio.2005.03.009","article-title":"Structural study of ribonucleotide reductase inhibitor hydrazones. Synthesis and X-ray diffraction analysis of a copper(II)-benzoylpyridine-2-quinolinyl hydrazone complex","volume":"99","author":"Tamasi","year":"2005","journal-title":"Journal of Inorganic Biochemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib13","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ejmech.2009.12.048","article-title":"A\u00a0novel copper complex of salicylaldehyde pyrazole hydrazone induces apoptosis through up-regulating integrin \u03b24 in H322 lung carcinoma cells","volume":"45","author":"Fan","year":"2010","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ica.2009.08.017","article-title":"Anticancer activity, structure, and theoretical calculation of N-(1-phenyl-3-methyl-4-propyl-pyrazolone-5)-salicylidene hydrazone and its copper(II) complex","volume":"363","author":"Zhang","year":"2010","journal-title":"Inorganica Chimica Acta"},{"key":"10.1016\/j.ejmech.2014.02.049_bib15","doi-asserted-by":"crossref","first-page":"7210","DOI":"10.1039\/c3dt50371b","article-title":"Potentially cytotoxic new copper(ii) hydrazone complexes: synthesis, crystal structure and biological properties","volume":"42","author":"Alagesan","year":"2013","journal-title":"Dalton Transactions"},{"key":"10.1016\/j.ejmech.2014.02.049_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejmech.2011.10.024","article-title":"Synthesis, crystal structure and pharmacological evaluation of two new Cu(II) complexes of 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (benzoyl) hydrazone: a comparative investigation","volume":"47","author":"Senthil Raja","year":"2012","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejmech.2013.03.040","article-title":"Synthesis, structure and in\u00a0vitro pharmacological evaluation of a novel 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (2\u2032-methylbenzoyl) hydrazone bridged copper(II) coordination polymer","volume":"64","author":"Senthil Raja","year":"2013","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib18","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.1039\/b903072g","article-title":"Four new dinuclear Cu(II) hydrazone complexes using various organic spacers: syntheses, crystal structures, DNA binding and cleavage studies and selective cell inhibitory effect towards leukemic and normal lymphocytes","author":"Banerjee","year":"2009","journal-title":"Dalton Transactions"},{"key":"10.1016\/j.ejmech.2014.02.049_bib19","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.jinorgbio.2011.08.022","article-title":"Synthesis, structure, DNA binding and cleavage properties of ternary amino acid Schiff base-phen\/bipy Cu(II) complexes","volume":"105","author":"Reddy","year":"2011","journal-title":"Journal of Inorganic Biochemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejmech.2012.09.051","article-title":"Synthesis and characterization of copper(II) and zinc(II)-based potential chemotherapeutic compounds: their biological evaluation viz. DNA binding profile, cleavage and antimicrobial activity","volume":"58","author":"Tabassum","year":"2012","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-8545(02)00100-5","article-title":"Biomedical uses and applications of inorganic chemistry. An overview","volume":"232","author":"Farrell","year":"2002","journal-title":"Coordination Chemistry Reviews"},{"key":"10.1016\/j.ejmech.2014.02.049_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jinorgbio.2011.09.034","article-title":"Synthesis, crystal structures, and biological evaluation of Cu(II) and Zn(II) complexes of 2-benzoylpyridine Schiff bases derived from S-methyl- and S-phenyldithiocarbazates","volume":"106","author":"Li","year":"2012","journal-title":"Journal of Inorganic Biochemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib23","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1158\/1535-7163.MCT-09-0016","article-title":"Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity","volume":"8","author":"Pfister","year":"2009","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/j.ejmech.2014.02.049_bib24","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1517\/14728222.12.10.1243","article-title":"Targeting topoisomerase I: molecular mechanisms and cellular determinants of response to topoisomerase I inhibitors","volume":"12","author":"Zunino","year":"2008","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"10.1016\/j.ejmech.2014.02.049_bib25","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1023\/A:1008270717294","article-title":"Topoisomerase I inhibitors: review and update","volume":"8","author":"Rothenberg","year":"1997","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.ejmech.2014.02.049_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.poly.2012.03.014","article-title":"Towards a selective cytotoxic agent for prostate cancer: interaction of zinc complexes of polyhydroxybenzaldehyde thiosemicarbazones with topoisomerase I","volume":"38","author":"Tan","year":"2012","journal-title":"Polyhedron"},{"key":"10.1016\/j.ejmech.2014.02.049_bib27","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1021\/ic700885m","article-title":"DNA binding and topoisomerase II inhibitory activity of water-soluble ruthenium(II) and rhodium(III) complexes","volume":"46","author":"Pandey","year":"2007","journal-title":"Inorganic Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib28","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1039\/c2dt12044e","article-title":"Molecular drug design, synthesis and structure elucidation of a new specific target peptide based metallo drug for cancer chemotherapy as topoisomerase i inhibitor","volume":"41","author":"Tabassum","year":"2012","journal-title":"Dalton Transactions"},{"key":"10.1016\/j.ejmech.2014.02.049_bib29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.poly.2003.11.005","article-title":"Spectral characterization, X-ray structure and biological investigations of copper(II) ternary complexes of 2-hydroxyacetophenone 4-hydroxybenzoic acid hydrazone and heterocyclic bases","volume":"23","author":"Sreeja","year":"2004","journal-title":"Polyhedron"},{"key":"10.1016\/j.ejmech.2014.02.049_bib30","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.poly.2006.11.035","article-title":"Synthesis, spectral characterization and crystal structure of copper(II) complexes of 2-hydroxyacetophenone-N(4)-phenyl semicarbazone","volume":"26","author":"Kala","year":"2007","journal-title":"Polyhedron"},{"key":"10.1016\/j.ejmech.2014.02.049_bib31","first-page":"779","article-title":"Dioxo- and oxovanadium(V) complexes of biomimetic hydrazone ONO donor ligands: synthesis, characterisation, and reactivity","author":"Maurya","year":"2001","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib32","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ica.2004.11.015","article-title":"Synthesis, structure and solution chemistry of mixed-ligand oxovanadium(IV) and oxovanadium(V) complexes incorporating tridentate ONO donor hydrazone ligands","volume":"358","author":"Ghosh","year":"2005","journal-title":"Inorganica Chimica Acta"},{"key":"10.1016\/j.ejmech.2014.02.049_bib33","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.poly.2011.09.021","article-title":"Synthesis, crystal structure, electrochemistry and studies on protein binding, antioxidant and biocidal activities of Ni(II) and Co(II) hydrazone complexes","volume":"31","author":"Sathyadevi","year":"2012","journal-title":"Polyhedron"},{"key":"10.1016\/j.ejmech.2014.02.049_bib34","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1039\/b413084g","article-title":"End-to-end single cyanato and thiocyanato bridged Cu(II) polymers with a new tridentate Schiff base ligand: crystal structure and magnetic properties","author":"Talukder","year":"2004","journal-title":"Dalton Transactions"},{"key":"10.1016\/j.ejmech.2014.02.049_bib35","doi-asserted-by":"crossref","first-page":"8347","DOI":"10.1039\/c3dt32992e","article-title":"Copper(II) complexes with 2NO and 3N donor ligands: synthesis, structures and chemical nuclease and anticancer activities","volume":"42","author":"Rajarajeswari","year":"2013","journal-title":"Dalton Transactions"},{"key":"10.1016\/j.ejmech.2014.02.049_bib36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1631-0748(02)01401-7","article-title":"How well do we understand self-assembly algorithms? From prototype grid to polymers","volume":"5","author":"Constable","year":"2002","journal-title":"Comptes Rendus Chimie"},{"key":"10.1016\/j.ejmech.2014.02.049_bib37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ica.2011.01.068","article-title":"Cu(II) complexes with square pyramidal (N 2S)CuCl 2 chromophore: Jahn-Teller distortion and subsequent effect on spectral and structural properties","volume":"370","author":"Roy","year":"2011","journal-title":"Inorganica Chimica Acta"},{"key":"10.1016\/j.ejmech.2014.02.049_bib38","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1039\/DT9840001349","article-title":"Synthesis, structure, and spectroscopic properties of copper(II) compounds containing nitrogen-sulphur donor ligands; the crystal and molecular structure of aqua[1,7-bis(N-methylbenzimidazol-2\u2032;-yl)-2,6-dithiaheptane]copper(II) perchlorate","author":"Addison","year":"1984","journal-title":"Journal of the Chemical Society, Dalton Transactions"},{"key":"10.1016\/j.ejmech.2014.02.049_bib39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jinorgbio.2012.04.018","article-title":"Efficient DNA cleavage mediated by mononuclear mixed ligand copper(II) phenolate complexes: the role of co-ligand planarity on DNA binding and cleavage and anticancer activity","volume":"114","author":"Jaividhya","year":"2012","journal-title":"Journal of Inorganic Biochemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib40","first-page":"539","article-title":"Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy","volume":"54","author":"Husain","year":"1994","journal-title":"Cancer Research"},{"key":"10.1016\/j.ejmech.2014.02.049_bib41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jinorgbio.2012.06.016","article-title":"[RuII(\u03b75-C5H5 (bipy)(PPh3)]+, a promising large spectrum antitumor agent: cytotoxic activity and interaction with human serum albumin","volume":"117","author":"Tomaz","year":"2012","journal-title":"Journal of Inorganic Biochemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib42","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.saa.2011.11.015","article-title":"Synthesis and structural characterization of ternary Cu (II) complexes of glycine with 2,2\u2032-bipyridine and 2,2\u2032-dipyridylamine. The DNA-binding studies and biological activity","volume":"86","author":"Mohamed","year":"2012","journal-title":"Spectrochimica Acta, Part A"},{"key":"10.1016\/j.ejmech.2014.02.049_bib43","doi-asserted-by":"crossref","first-page":"10233","DOI":"10.1039\/c3dt50884f","article-title":"Ternary copper(II)-polypyridyl enantiomers: aldol-type condensation, characterization, DNA-binding recognition, BSA-binding and anticancer property","volume":"42","author":"Ng","year":"2013","journal-title":"Dalton Transactions"},{"key":"10.1016\/j.ejmech.2014.02.049_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinorgbio.2013.09.013","article-title":"New water-soluble ruthenium(II) cytotoxic complex: biological activity and cellular distribution","volume":"130","author":"Morais","year":"2014","journal-title":"Journal of Inorganic Biochemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib45","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1039\/C1DT11273B","article-title":"Ruthenium(II)\/(III) complexes of 4-hydroxy-pyridine-2,6-dicarboxylic acid with PPh 3\/AsPh 3 as co-ligand: impact of oxidation state and co-ligands on anticancer activity in\u00a0vitro","volume":"41","author":"Kamatchi","year":"2012","journal-title":"Dalton Transactions"},{"key":"10.1016\/j.ejmech.2014.02.049_bib46","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ccr.2007.04.006","article-title":"Targeting the mitochondrial cell death pathway with gold compounds","volume":"251","author":"Barnard","year":"2007","journal-title":"Coordination Chemistry Reviews"},{"key":"10.1016\/j.ejmech.2014.02.049_bib47","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.bcp.2007.07.022","article-title":"A\u00a0gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: implications for anticancer therapeutics targeted to mitochondria","volume":"74","author":"Rackham","year":"2007","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.ejmech.2014.02.049_bib48","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1016\/j.ejmech.2011.05.039","article-title":"Non-substituted N-heteroaromatic selenosemicarbazone metal complexes induce apoptosis in cancer cells via activation of mitochondrial pathway","volume":"46","author":"Srdi\u0107-Raji\u0107","year":"2011","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib49","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1021\/jm801641t","article-title":"Synthesis and biological activities of topoisomerase I inhibitors, 6-arylmethylamino analogues of edotecarin","volume":"52","author":"Sunami","year":"2009","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib50","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc1977","article-title":"Topoisomerase I inhibitors: camptothecins and beyond","volume":"6","author":"Pommier","year":"2006","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.ejmech.2014.02.049_bib51","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.bcp.2007.10.016","article-title":"Next generation topoisomerase I inhibitors: rationale and biomarker strategies","volume":"75","author":"Teicher","year":"2008","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.ejmech.2014.02.049_bib52","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.bi.65.070196.003223","article-title":"DNA topoisomerases","volume":"65","author":"Wang","year":"1996","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib53","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrm831","article-title":"Cellular roles of DNA topoisomerases: a molecular perspective","volume":"3","author":"Wang","year":"2002","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.1016\/j.ejmech.2014.02.049_bib54","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1016\/j.ejmech.2009.02.004","article-title":"Novel topoisomerase I-targeting antitumor agents synthesized from the N, N,N-trimethylammonium derivative of ARC-111, 5H-2,3-dimethoxy-8,9-methylenedioxy-5-[(2-N, N,N-trimethylammonium)ethyl]dibenzo[c,h][1,6]naphthyridin-6-one iodide","volume":"44","author":"Feng","year":"2009","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib55","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1158\/1535-7163.MCT-05-0456","article-title":"A\u00a0novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex","volume":"5","author":"Marchand","year":"2006","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/j.ejmech.2014.02.049_bib56","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1021\/ic025810l","article-title":"Synthesis, characterization, and DNA binding properties of a series of Ru, Pt mixed-metal complexes","volume":"42","author":"Williams","year":"2003","journal-title":"Inorganic Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib57","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0168-3659(97)00173-9","article-title":"Preparation of chitosan self-aggregates as a gene delivery system","volume":"51","author":"Lee","year":"1998","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.ejmech.2014.02.049_bib58","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jinorgbio.2004.11.018","article-title":"Mixed ligand copper(II) complexes of phenanthroline\/bipyridyl and curcumin diketimines as DNA intercalators and their electrochemical behavior under Nafion\u00ae and clay modified electrodes","volume":"99","author":"Annaraj","year":"2005","journal-title":"Journal of Inorganic Biochemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib59","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1021\/ic062059y","article-title":"Cleavage of C\u2013S bonds with the formation of a tetranuclear Cu(I) cluster","volume":"46","author":"Huang","year":"2007","journal-title":"Inorganic Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib60","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1021\/jm0704088","article-title":"64Cu-labeled triphenylphosphonium and triphenylarsonium cations as highly tumor-selective imaging agents","volume":"50","author":"Wang","year":"2007","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib61","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","article-title":"A\u00a0short history of SHELX","volume":"64","author":"Sheldrick","year":"2007","journal-title":"Acta Crystallographica, Section A: Foundations of Crystallography"},{"key":"10.1016\/j.ejmech.2014.02.049_bib62","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1472-7862(02)00030-8","article-title":"X-seed \u2013 a software tool for supramolecular crystallography","volume":"1","author":"Barbour","year":"2001","journal-title":"Journal of Supramolecular Chemistry"},{"key":"10.1016\/j.ejmech.2014.02.049_bib63","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"Journal of Immunological Methods"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341400169X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341400169X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T07:18:47Z","timestamp":1716535127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352341400169X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":63,"alternative-id":["S022352341400169X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.02.049","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Copper complexes with phosphonium containing hydrazone ligand: Topoisomerase inhibition and cytotoxicity study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.02.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}